The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

被引：36

作者：

Zhang, Ye ^{[1
]}

Yan, Wen-Ting ^{[1
]}

Yang, Ze-Yu ^{[2
]}

Li, Yan-Ling ^{[1
]}

Tan, Xuan-Ni ^{[1
]}

Jiang, Jun ^{[1
]}

Zhang, Yi ^{[1
]}

Qi, Xiao-Wei ^{[1
]}

机构：

[1] Army Med Univ, Southwest Hosp, Breast & Thyroid Surg, Gaotanyan St 29, Chongqing 400038, Peoples R China

[2] Univ Chinese Acad Sci, Chongqing Gen Hosp, Breast & Thyroid Surg, Chongqing 400013, Peoples R China

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2020年 / 16卷 / 08期

基金：

中国国家自然科学基金;

关键词：

WT1; breast neoplasms; prognosis; carcinogenesis; TUMOR SUPPRESSOR GENE; ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL REGULATION; WILMS-TUMOR-1; PROTEIN; DOWN-REGULATION; POOR-PROGNOSIS; EXPRESSION; ISOFORMS; GROWTH; PROLIFERATION;

D O I：

10.7150/ijbs.39958

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although Wilms' tumor gene 1 (WT1) was first cloned and identified as a tumor suppressor gene in nephroblastoma, subsequent studies have demonstrated that it can also play an oncogenic role in leukemia and various solid tumors. WT1 exerts biological functions with high tissue- and cell-specificity. This article reviews the relationship between WT1 and breast cancer from two aspects: (1) clinical application of WT1, including the relationship between expression of WT1 and prognosis of breast cancer patients, and its effectiveness as a target for comprehensive therapy of breast cancer; (2) the biological effects and molecular mechanisms of WT1 in the development and progression of breast cancer, including proliferation, apoptosis, invasion, and metastasis of breast cancer cells.

引用

页码：1474 / 1480

页数：7

共 50 条

[1] Clinical and molecular evidence for the role of androgens and WT1 in testis descent
Lim, HN
Hughes, IA
Hawkins, JR
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 185 (1-2) : 43 - 50
[2] BMI-1 in Breast Cancer- Biological Role and Clinical Implications
Szustka, Aleksandra
Krzeslak, Anna
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2024, 58 (05) : 584 - 596
[3] The association of oncogenic role between WT1 and p53 in breast cancer
Kanokwiroon, K.
Graidist, P.
FEBS JOURNAL, 2012, 279 : 59 - 59
[4] The effect of WT1 on aggressiveness of triple negative breast cancer
Bissanum, Rassanee
Navakanitworakul, Raphatphom
Lirdprapamongkol, Kriengsak
Kanokwiroon, Kanyanatt
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S55 - S55
[5] Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms
Ben Haj Othmen, Hind
Othman, Houcemeddine
Khamessi, Oussema
Bettaieb, Ilhem
Gara, Sonia
Kharrat, Maher
MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
[6] THE ROLE OF WT1 IN WILMS TUMORIGENESIS
COPPES, MJ
CAMPBELL, CE
WILLIAMS, BRG
FASEB JOURNAL, 1993, 7 (10): : 886 - 895
[7] The role of WT1 gene in neuroblastoma
Wang, Jingfu
Oue, Takaharu
Uehara, Shuichiro
Yamanaka, Hiroaki
Oji, Yusuke
Fukuzawa, Masahiro
JOURNAL OF PEDIATRIC SURGERY, 2011, 46 (02) : 326 - 331
[8] Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer
Pishbin, Fariba
Ziamajidi, Nasrin
Abbasalipourkabir, Roghayeh
Najafi, Rezvan
Farhadian, Maryam
PERSONALIZED MEDICINE, 2021, 18 (01) : 31 - 42
[9] Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast Cancer
Arpino, Grazia
De Angelis, Carmine
Giuliano, Mario
Giordano, Antonio
Falato, Claudette
De Laurentiis, Michele
De Placido, Sabino
ONCOLOGY, 2009, 77 : 23 - 37
[10] IDENTIFICATION OF AN ANTISENSE WT1 PROMOTER IN INTRON-1 - IMPLICATIONS FOR WT1 GENE-REGULATION
MALIK, KTA
WALLACE, JI
IVINS, SM
BROWN, KW
ONCOGENE, 1995, 11 (08) : 1589 - 1595

← 1 2 3 4 5 →